Roundhouse AI

magent

Cooperberg 2005 UCSF CAPRA preoperative score (Table 1). Caller-assigned PSA (>=2.1-6 0, >6-10 1, >10-20 2, >20-30 3, >30 4), Gleason 1-3/1-3 0, 1-3/4-5 1, primary 4-5 3, clinical T t1/t2 0 or t3a 1, percent positive biopsies <34 0 or >=34 1, age <50 0 or >=50 1. Score 0-10. Table 4 bands 0_1, 2, 3, 4, 5, 6, ge_7 with 5-year RFS 85/81/66/59/60/34/8. Not Kattan. Not D'Amico. Not CAPRA-S. magent does not assay PSA or read biopsies. Not a diagnosis. Not a medical device.

DataLiveeip155:8453Exactvia cdp
https://api.magentlab.com/api/calc/capra
CapraProstateCooperbergPrognosisCalculator
Calls · 30d
1→ 0%
This endpoint's own trailing-30-day call count, as published by the upstream catalog and snapshotted daily. 10 snapshots so far.
$13.75
Verified settled volume
2,750 settlements proven x402 by their on-chain EIP-3009 marker.
$0.0050
Listed price
As published in the catalog. Always read the live 402 before paying.
1
Calls · 30d
Upstream's own call count for this endpoint, not ours.
1
Unique payers · 30d
Last called 2026-08-31 13:00Z
—
Upstream on-chain volume
Reported by the source catalog.
Paid to
0x836Be278f1739fB4308091cD1852F7971Bc19Ee2

The wallet the 402 directs payment to. Its whole payment record — every payer, every chain — is on the merchant page.

Asset 0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913

Provider

The payTo wallet does not resolve to a registered ERC-8004 agent. That is not a verdict on the service — most of the catalog is unregistered.

Live 402 challenge

Captured by the enrichment pass, not read just now. Prices can change — always read the 402 the endpoint answers with.

{
  "error": "PAYMENT-SIGNATURE header is required",
  "accepts": [
    {
      "asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
      "extra": {
        "name": "USD Coin",
        "version": "2",
        "paymentFlow": "upfront",
        "resourceUrl": "https://api.magentlab.com/api/calc/capra",
        "assetTransferMethod": "eip3009"
      },
      "payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2",
      "amount": "5000",
      "scheme": "exact",
      "network": "eip155:8453",
      "maxTimeoutSeconds": 600
    },
    {
      "asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
      "extra": {
        "name": "USD Coin",
        "version": "2",
        "withdrawDelay": 86400,
        "receiverAuthorizer": "0x3721824a31197dcDD2984cF43b92B6cc8A87c0Fb",
        "assetTransferMethod": "eip3009"
      },
      "payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2",
      "amount": "5000",
      "scheme": "batch-settlement",
      "network": "eip155:8453",
      "maxTimeoutSeconds": 600
    }
  ],
  "resource": {
    "url": "https://api.magentlab.com/api/calc/capra",
    "tags": [
      "capra",
      "prostate",
      "cooperberg",
      "prognosis",
      "calculator"
    ],
    "mimeType": "application/json",
    "description": "Cooperberg 2005 UCSF CAPRA preoperative score (Table 1). Caller-assigned PSA (>=2.1-6 0, >6-10 1, >10-20 2, >20-30 3, >30 4), Gleason 1-3/1-3 0, 1-3/4-5 1, primary 4-5 3, clinical T t1/t2 0 or t3a 1, percent positive biopsies <34 0 or >=34 1, age <50 0 or >=50 1. Score 0-10. Table 4 bands 0_1, 2, 3, 4, 5, 6, ge_7 with 5-year RFS 85/81/66/59/60/34/8. Not Kattan. Not D'Amico. Not CAPRA-S. magent does not assay PSA or read biopsies. Not a diagnosis. Not a medical device.",
    "serviceName": "magent"
  },
  "extensions": {
    "bazaar": {
      "info": {
        "input": {
          "type": "http",
          "method": "GET",
          "queryParams": {
            "age": 62,
            "t_stage": "t1",
            "psa_ng_ml": 5,
            "gleason_primary": 3,
            "gleason_secondary": 3,
            "percent_positive_biopsies": 20
          }
        },
        "output": {
          "type": "json",
          "example": {
            "band": "0_1",
            "score": 1,
            "formula": "capra",
            "t_stage": "t1",
            "citation": {
              "id": "cooperberg-2005",
              "doi": "10.1097/01.ju.0000158155.33890.e7",
              "pmid": "15879786",
              "title": "The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy",
              "source": "J Urol. 2005;173(6):1938-1942",
              "authors": "Cooperberg MR, Pasta DJ, Elkin EP, Litwin MS, Latini DM, Du Chane J, Carroll PR"
            },
            "age_years": 62,
            "max_score": 10,
            "psa_ng_ml": 5,
            "components": [
              {
                "value": 5,
                "factor": "psa_ng_ml",
                "points": 0,
                "present": true
              },
              {
                "value": "3+3",
                "factor": "gleason",
                "points": 0,
                "present": true
              },
              {
                "value": "t1",
                "factor": "t_stage",
                "points": 0,
                "present": true
              },
              {
                "value": 20,
                "factor": "percent_positive_biopsies",
                "points": 0,
                "present": true
              },
              {
                "value": 62,
                "factor": "age",
                "points": 1,
                "present": true
              }
            ],
            "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
            "rfs_5y_percent": 85,
            "gleason_primary": 3,
            "gleason_secondary": 3,
            "formula_expression": "CAPRA (Cooperberg 2005 Table 1) = psa_ng_ml (>=2.1 and <=6.0 0, >6.0 and <=10.0 1, >10.0 and <=20.0 2, >20.0 and <=30.0 3, >30 4; PSA <2.1 excluded) + gleason (primary/secondary 1-3/1-3 0, 1-3/4-5 1, primary 4-5 3) + t_stage (t1 or t2 0, t3a 1) + percent_positive_biopsies (<34 0, >=34 1) + age (<50 0, >=50 1); score 0-10; Table 4 Kaplan-Meier bands 0_1 / 2 / 3 / 4 / 5 / 6 / ge_7 with 5-year RFS 85 / 81 / 66 / 59 / 60 / 34 / 8. Not Kattan nomogram. Not D'Amico groups. Not CAPRA-S",
            "percent_positive_biopsies": 20
          }
        },
        "iconUrl": "https://api.magentlab.com/favicon.ico"
      },
      "schema": {
        "type": "object",
        "$schema": "https://json-schema.org/draft/2020-12/schema",
        "required": [
          "input"
        ],
        "properties": {
          "input": {
            "type": "object",
            "required": [
              "type",
              "method"
            ],
            "properties": {
              "type": {
                "type": "string",
                "const": "http"
              },
              "method": {
                "enum": [
                  "GET",
                  "HEAD",
                  "DELETE"
                ],
                "type": "string"
              },
              "headers": {
                "type": "object",
                "additionalProperties": {
                  "type": "string"
                }
              },
              "queryParams": {
                "type": "object",
                "required": [
                  "age",
                  "psa_ng_ml",
                  "gleason_primary",
                  "gleason_secondary",
                  "t_stage",
                  "percent_positive_biopsies"
                ],
                "properties": {
                  "age": {
                    "type": "integer",
                    "description": "Age in years (18-120, Params.age). Cooperberg 2005 Table 1: <50 scores 0; >=50 scores 1."
                  },
                  "t_stage": {
                    "enum": [
                      "t1",
                      "t2",
                      "t3a"
                    ],
                    "type": "string",
                    "description": "Clinical T as assigned by the caller (Cooperberg 2005 Table 1). t1 or t2 scores 0; t3a scores 1. Other stages are invalid. Not CAPRA-S pathologic T. magent does not assign TNM."
                  },
                  "psa_ng_ml": {
                    "type": "number",
                    "description": "Preoperative PSA in ng/mL as assigned by the caller (2.1-500). Cooperberg 2005 Table 1: >=2.1 and <=6.0 scores 0; >6.0 and <=10.0 scores 1; >10.0 and <=20.0 scores 2; >20.0 and <=30.0 scores 3; >30 scores 4. PSA <2.1 is invalid (paper excluded PSA <2). magent does not assay PSA."
                  },
                  "gleason_primary": {
                    "type": "integer",
                    "description": "Primary Gleason pattern 1-5 as assigned by the caller (Cooperberg 2005 Table 1). Integer 1-5 only. Combined with gleason_secondary: 1-3/1-3 scores 0; 1-3/4-5 scores 1; primary 4-5 scores 3. magent does not read biopsies."
                  },
                  "gleason_secondary": {
                    "type": "integer",
                    "description": "Secondary Gleason pattern 1-5 as assigned by the caller (Cooperberg 2005 Table 1). Integer 1-5 only. Combined with gleason_primary as above. magent does not read biopsies."
                  },
                  "percent_positive_biopsies": {
                    "type": "number",
                    "description": "Percent of biopsy cores positive (0-100) as assigned by the caller (Cooperberg 2005 Table 1). <34 scores 0; >=34 scores 1. magent does not read biopsies."
                  }
                }
              }
            },
            "additionalProperties": false
          },
          "output": {
            "type": "object",
            "required": [
              "type"
            ],
            "properties": {
              "type": {
                "type": "string"
              },
              "example": {
                "type": "object"
              }
            }
          }
        }
      }
    }
  },
  "x402Version": 2
}

Accepts

The payment requirements as published to the catalog. Read the live 402 before paying — a price here is a claim, not a quote.

0.005USDC≈ $0.005 USD
on Base · exact scheme

Pay 0.005 USDC on Base to 0x836B…19Ee2. The signed payment is good for 10 minutes.

Paid to
0x836B…19Ee2
USD Coin contract
0x8335…02913
Payment window
10 minutes
As published
5000 smallest units
The catalog’s raw entry
[
  {
    "asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
    "extra": {
      "name": "USD Coin",
      "version": "2",
      "paymentFlow": "upfront",
      "resourceUrl": "https://api.magentlab.com/api/calc/capra",
      "assetTransferMethod": "eip3009"
    },
    "payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2",
    "amount": "5000",
    "scheme": "exact",
    "network": "eip155:8453",
    "maxTimeoutSeconds": 600
  }
]

Extensions

{
  "bazaar": {
    "info": {
      "input": {
        "body": {
          "items": [
            {
              "age": 62,
              "t_stage": "t1",
              "psa_ng_ml": 5,
              "gleason_primary": 3,
              "gleason_secondary": 3,
              "percent_positive_biopsies": 20
            },
            {
              "age": 62,
              "t_stage": "t1",
              "psa_ng_ml": 5,
              "gleason_primary": 3,
              "gleason_secondary": 3,
              "percent_positive_biopsies": 20
            }
          ]
        },
        "type": "http",
        "method": "POST"
      },
      "output": {
        "type": "json",
        "example": {
          "path": "/api/calc/capra",
          "count": 2,
          "items": [
            {
              "band": "0_1",
              "score": 1,
              "formula": "capra",
              "t_stage": "t1",
              "citation": {
                "id": "cooperberg-2005",
                "doi": "10.1097/01.ju.0000158155.33890.e7",
                "pmid": "15879786",
                "title": "The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy",
                "source": "J Urol. 2005;173(6):1938-1942",
                "authors": "Cooperberg MR, Pasta DJ, Elkin EP, Litwin MS, Latini DM, Du Chane J, Carroll PR"
              },
              "age_years": 62,
              "max_score": 10,
              "psa_ng_ml": 5,
              "components": [
                {
                  "value": 5,
                  "factor": "psa_ng_ml",
                  "points": 0,
                  "present": true
                },
                {
                  "value": "3+3",
                  "factor": "gleason",
                  "points": 0,
                  "present": true
                },
                {
                  "value": "t1",
                  "factor": "t_stage",
                  "points": 0,
                  "present": true
                },
                {
                  "value": 20,
                  "factor": "percent_positive_biopsies",
                  "points": 0,
                  "present": true
                },
                {
                  "value": 62,
                  "factor": "age",
                  "points": 1,
                  "present": true
                }
              ],
              "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
              "rfs_5y_percent": 85,
              "gleason_primary": 3,
              "gleason_secondary": 3,
              "formula_expression": "CAPRA (Cooperberg 2005 Table 1) = psa_ng_ml (>=2.1 and <=6.0 0, >6.0 and <=10.0 1, >10.0 and <=20.0 2, >20.0 and <=30.0 3, >30 4; PSA <2.1 excluded) + gleason (primary/secondary 1-3/1-3 0, 1-3/4-5 1, primary 4-5 3) + t_stage (t1 or t2 0, t3a 1) + percent_positive_biopsies (<34 0, >=34 1) + age (<50 0, >=50 1); score 0-10; Table 4 Kaplan-Meier bands 0_1 / 2 / 3 / 4 / 5 / 6 / ge_7 with 5-year RFS 85 / 81 / 66 / 59 / 60 / 34 / 8. Not Kattan nomogram. Not D'Amico groups. Not CAPRA-S",
              "percent_positive_biopsies": 20
            },
            {
              "band": "0_1",
              "score": 1,
              "formula": "capra",
              "t_stage": "t1",
              "citation": {
                "id": "cooperberg-2005",
                "doi": "10.1097/01.ju.0000158155.33890.e7",
                "pmid": "15879786",
                "title": "The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy",
                "source": "J Urol. 2005;173(6):1938-1942",
                "authors": "Cooperberg MR, Pasta DJ, Elkin EP, Litwin MS, Latini DM, Du Chane J, Carroll PR"
              },
              "age_years": 62,
              "max_score": 10,
              "psa_ng_ml": 5,
              "components": [
                {
                  "value": 5,
                  "factor": "psa_ng_ml",
                  "points": 0,
                  "present": true
                },
                {
                  "value": "3+3",
                  "factor": "gleason",
                  "points": 0,
                  "present": true
                },
                {
                  "value": "t1",
                  "factor": "t_stage",
                  "points": 0,
                  "present": true
                },
                {
                  "value": 20,
                  "factor": "percent_positive_biopsies",
                  "points": 0,
                  "present": true
                },
                {
                  "value": 62,
                  "factor": "age",
                  "points": 1,
                  "present": true
                }
              ],
              "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
              "rfs_5y_percent": 85,
              "gleason_primary": 3,
              "gleason_secondary": 3,
              "formula_expression": "CAPRA (Cooperberg 2005 Table 1) = psa_ng_ml (>=2.1 and <=6.0 0, >6.0 and <=10.0 1, >10.0 and <=20.0 2, >20.0 and <=30.0 3, >30 4; PSA <2.1 excluded) + gleason (primary/secondary 1-3/1-3 0, 1-3/4-5 1, primary 4-5 3) + t_stage (t1 or t2 0, t3a 1) + percent_positive_biopsies (<34 0, >=34 1) + age (<50 0, >=50 1); score 0-10; Table 4 Kaplan-Meier bands 0_1 / 2 / 3 / 4 / 5 / 6 / ge_7 with 5-year RFS 85 / 81 / 66 / 59 / 60 / 34 / 8. Not Kattan nomogram. Not D'Amico groups. Not CAPRA-S",
              "percent_positive_biopsies": 20
            }
          ]
        }
      },
      "iconUrl": "https://api.magentlab.com/favicon.ico"
    },
    "schema": {
      "type": "object",
      "$schema": "https://json-schema.org/draft/2020-12/schema",
      "required": [
        "input"
      ],
      "properties": {
        "input": {
          "type": "object",
          "required": [
            "type",
            "method"
          ],
          "properties": {
            "body": {
              "type": "object",
              "required": [
                "items"
              ],
              "properties": {
                "items": {
                  "type": "array",
                  "items": {
                    "type": "object",
                    "required": [
                      "age",
                      "psa_ng_ml",
                      "gleason_primary",
                      "gleason_secondary",
                      "t_stage",
                      "percent_positive_biopsies"
                    ],
                    "properties": {
                      "age": {
                        "type": "integer",
                        "description": "Age in years (18-120, Params.age). Cooperberg 2005 Table 1: <50 scores 0; >=50 scores 1."
                      },
                      "t_stage": {
                        "enum": [
                          "t1",
                          "t2",
                          "t3a"
                        ],
                        "type": "string",
                        "description": "Clinical T as assigned by the caller (Cooperberg 2005 Table 1). t1 or t2 scores 0; t3a scores 1. Other stages are invalid. Not CAPRA-S pathologic T. magent does not assign TNM."
                      },
                      "psa_ng_ml": {
                        "type": "number",
                        "description": "Preoperative PSA in ng/mL as assigned by the caller (2.1-500). Cooperberg 2005 Table 1: >=2.1 and <=6.0 scores 0; >6.0 and <=10.0 scores 1; >10.0 and <=20.0 scores 2; >20.0 and <=30.0 scores 3; >30 scores 4. PSA <2.1 is invalid (paper excluded PSA <2). magent does not assay PSA."
                      },
                      "gleason_primary": {
                        "type": "integer",
                        "description": "Primary Gleason pattern 1-5 as assigned by the caller (Cooperberg 2005 Table 1). Integer 1-5 only. Combined with gleason_secondary: 1-3/1-3 scores 0; 1-3/4-5 scores 1; primary 4-5 scores 3. magent does not read biopsies."
                      },
                      "gleason_secondary": {
                        "type": "integer",
                        "description": "Secondary Gleason pattern 1-5 as assigned by the caller (Cooperberg 2005 Table 1). Integer 1-5 only. Combined with gleason_primary as above. magent does not read biopsies."
                      },
                      "percent_positive_biopsies": {
                        "type": "number",
                        "description": "Percent of biopsy cores positive (0-100) as assigned by the caller (Cooperberg 2005 Table 1). <34 scores 0; >=34 scores 1. magent does not read biopsies."
                      }
                    }
                  },
                  "maxItems": 25,
                  "minItems": 1
                }
              },
              "additionalProperties": false
            },
            "type": {
              "type": "string",
              "const": "http"
            },
            "method": {
              "type": "string",
              "const": "POST"
            },
            "headers": {
              "type": "object",
              "additionalProperties": {
                "type": "string"
              }
            }
          },
          "additionalProperties": false
        },
        "output": {
          "type": "object",
          "required": [
            "type"
          ],
          "properties": {
            "type": {
              "type": "string"
            },
            "example": {
              "type": "object"
            }
          }
        }
      }
    }
  }
}

Provenance

Seen in the source catalog
2026-08-31 13:00Z
Last indexed by Roundhouse
2026-09-07 06:20Z
Last enriched (probe, favicon, geo)
2026-09-22 12:45Z
x402 version
2
Max timeout
600s
Liveness probe
HTTP 402
Report

Hand this page to an agent

Copy the prompt and paste it into Claude, an MCP client or your own agent — it will vet this service and call it over the free read API. No key, no account.

GET api.roundhouseai.io/v0/endpoints

This endpoint's own trailing-30-day call count, as published by the upstream catalog and snapshotted daily. 10 snapshots so far. Verified volume counts only settlements with an on-chain EIP-3009 marker.

Open skill.md
Show the prompt
Using Roundhouse, look up the x402 service magent and tell me whether it is
worth paying: what a call costs, whether the endpoint answered when last probed, and what
its payment record actually shows.

curl -s 'https://api.roundhouseai.io/v0/endpoints?q=magent'
curl -s 'https://api.roundhouseai.io/v0/merchants/<the payTo wallet returned above>'

Then call it: read the price from the live 402 at https://api.magentlab.com/api/calc/capra, never from
a cached figure, and pay with an x402 client.

The /v0 API needs an API key (`authorization: Bearer rh_live_…`) on everything except
/v0/unified* and /v0/endpoints. Mint a personal key for $0.01 at GET https://api.roundhouseai.io/v0/test/x402,
or use an organization key from https://roundhouseai.io/dashboard/team.

If you do not have Roundhouse tools or skills installed, read
https://roundhouseai.io/skill.md first — it is the whole procedure.